A Mutation in Plasma Platelet-Activating Factor Acetylhydrolase (Val 279 →Phe) is a Genetic Risk Factor for Stroke
Data up to Jan 2025
Total Citations Per Year
Abstract
References (31)
The pathogenesis of atherosclerosis: a perspective for the 1990s
1993 • 10,730 citations
Special report from the National Institute of Neurological Disorders and Stroke. Classification of cerebrovascular diseases III.
1990 • 1,206 citations
Mutation in the Gene Coding for Coagulation Factor V and the Risk of Myocardial Infarction, Stroke, and Venous Thrombosis in Apparently Healthy Men
1995 • 1,060 citations
Anti-inflammatory properties of a platelet-activating factor acetylhydrolase
1995 • 529 citations
Endothelial cell-associated platelet-activating factor: a novel mechanism for signaling intercellular adhesion.
1990 • 391 citations
Human plasma platelet-activating factor acetylhydrolase. Purification and properties.
1987 • 335 citations
Characterization of serum platelet-activating factor (PAF) acetylhydrolase. Correlation between deficiency of serum PAF acetylhydrolase and respiratory symptoms in asthmatic children.
1988 • 285 citations
Platelet-activating factor acetylhydrolase deficiency. A missense mutation near the active site of an anti-inflammatory phospholipase.
1996 • 270 citations
Familial aggregation of stroke. The Framingham Study.
1993 • 256 citations
A study of twins and stroke.
1992 • 254 citations
Platelet-activating factor as a potential retrograde messenger in CA1 hippocampal long-term potentiation
1994 • 251 citations
Platelet‐activating factor: a mediator for clinicians
1995 • 148 citations
Factor V Leiden Gene Mutation and Thrombin Generation in Relation to the Development of Acute Stroke
1995 • 127 citations
Apolipoprotein E Polymorphism and Stroke in a Population Sample Aged 75 Years or More
1996 • 112 citations
Mammalian platelet-activating factor acetylhydrolases
1996 • 109 citations
Plasma degradation of platelet-activating factor in severely ill patients with clinical sepsis
1994 • 108 citations
Antihypertensive functions of the kidney: Arthur C. Corcoran memorial lecture.
1980 • 108 citations
Evidence for platelet-activating factor as a novel mediator in experimental stroke in rabbits.
1990 • 106 citations
Coronary vasoconstriction in the rat, isolated perfused heart induced by platelet‐activating factor is mediated by leukotriene C4
1986 • 95 citations
Release of Platelet-Activating Factor in Systemic Lupus erythematosus
1990 • 81 citations
FAMILY HISTORY OF STROKE AS AN INDEPENDENT PREDICTOR OF ISCHIEMTC HEART DISEASE IN MEN AND STROKE IN WOMEN
1986 • 81 citations
Platelet-activating factor (PAF) stimulates the production of PAF acetylhydrolase by the human hepatoma cell line, HepG2.
1991 • 77 citations
Activity of platelet-activating factor (PAF) acetylhydrolase in plasma from patients with ischemic cerebrovascular disease
1988 • 68 citations
Increased activity of the platelet-activating factor acetylhydrolase in plasma low density lipoprotein from patients with essential hypertension
1989 • 68 citations
Platelet-activating factor acetylhydrolase in plasma lipoproteins from patients with ischemic stroke.
1992 • 55 citations
The Role of Platelet-Activating Factor in Endothelial Cells
1990 • 48 citations
Mechanism(s) of the hypotensive effect of synthetic 1-O-octadecyl-2-O-acetyl-glycero-3-phosphorylcholine
1984 • 42 citations
Plasma platelet-activating factor degradation in patients with severe coronary artery disease
1992 • 35 citations
The Role of Platelet‐Activating Factor in Cerebral Ischemia and Related Disorders
1989 • 27 citations
Variation in plasma platelet-activating factor degradation and serum lipids after acute myocardial infarction
1993 • 24 citations
Deficiency of plasma platelet-activating factor acetylhydrolase: Roles of blood cells
1996 • 18 citations